Page 290 - 2025中醫藥與天然藥物聯合學術研討會-中醫藥與天然藥物的挑戰X機遇與未來大會手冊
P. 290

CM-23


               Effect  and  possible  mechanism  of  HUPA  on  FCA-induced  rheumatoid

               arthritis model in mice


                                    ,1
               Ching-Wen Chang,*  Y u -Chin Lin    2

               1  Department of Cosmetic Applications and Management, MacKay Junior College of
                 Medicine, Nursing, and Management, Taipei 112021, Taiwan
               2  Department of Medicinal Botanicals and Foods on Health Applications, Da-Yeh University,
                 Changhua 515006, Taiwan
               * E-mail: s472@mail.mkc.edu.tw

               Abstract
                  This  project  aimed  to  establish  a  rheumatoid  arthritis  (RA)  model  in  mice  induced  by
               Complete Freund's adjuvant (CFA) and to evaluate the therapeutic potential of huperzine A
               (HupA). RA is a chronic autoimmune disease characterized by synovitis, pannus formation,
               cartilage erosion, and bone destruction. Its underlying mechanisms remain largely unclear, and
               current treatments, although effective, are limited by significant side effects. As the disease
               progresses,  patients  often  suffer  from  joint  pain,  swelling,  deformity,  disability,  organ
               dysfunction, and mental disorders, making RA a major challenge in global medicine. Inhibiting
               the inflammatory response has been recognized as an important strategy to prevent disease
               progression.  Lycopodium  serratum  var.  longipetiolatum,  a  traditional  Taiwanese  herbal
               medicine, has long been used for its analgesic effects. HupA, one of its active ingredients, is
               widely studied for Alzheimer’s disease and has also been reported to exert analgesic and anti-
               inflammatory effects. In this study, mice with CFA-induced RA exhibited inflammation and
               swelling  in  the spleen,  ankle joints,  and paws,  confirming successful  model establishment.
               Treatment with HupA (100 μg/kg) significantly reduced the levels of IL-6, IL-1β, TNF-α, and
               NO  in  joint  tissues,  thereby  alleviating  both  local  and  systemic  inflammatory  responses.
               Histological  analyses  showed  that  induced  groups  developed  varying  degrees  of  chronic
               inflammation,  villous  hyperplasia,  and  granulomatous  dermatitis,  whereas  no  pathological
               abnormalities were observed in the heart, kidneys, or spleen. These findings suggest that HupA
               has the potential to mitigate RA-related inflammation and joint damage.

               Keywords: Rheumatoid arthritis; Complete Freund's adjuvant; Huperzine A; anti-inflammatory
                           effect
   285   286   287   288   289   290   291   292   293   294   295